Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study on the Safety of GEN1053 Alone and with an Immunomodulator for Patients with Malignant Solid Tumors
SpainStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
BelgiumStudy on the Safety and Effectiveness of BCMACP03 for Patients with Relapsed or Refractory Multiple Myeloma
BelgiumStudy of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer
FranceStudy of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma
DenmarkStudy of Pembrolizumab for Patients with Advanced Solid Tumors
DenmarkStudy on Acetazolamide with Radiochemotherapy or Radioimmunotherapy for Patients with Small Cell Lung Cancer
FranceStudy Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer
FranceStudy of DKN-01 with Drug Combination for Patients with Advanced Colorectal Cancer
GermanyStudy on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma
AustriaStudy on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia
AustriaStudy on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy
AustriaThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
